Internal Medicine · Sylva, NC
NPI
1760440812
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
98 Doctors Dr, Suite 200
Sylva, NC, 28779
Phone (828) 586-8971
Groups this clinician bills Medicare through
Medicare paid, 2024
$66K
965 services
Medicare patients, 2024
317
Average age 76
Drug cost, 2024
$1.4M
13,660 prescriptions
Company payments, 2025
$1,160
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Steven W Queen was code 99214 (office e&m - established), 465 times for 253 patients. In total Steven W Queen billed 965 services in 20 codes, and Medicare paid $66K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-09-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 465 | 253 | $60.93 | $28K |
| 99213 Office E&M - Established | Office | 245 | 166 | $36.59 | $8,965 |
| G0438 Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 73 | 73 | $167.46 | $12K |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 68 | 68 | $131.52 | $8,944 |
| 99215 Office E&M - Established | Office | 51 | 42 | $101.44 | $5,174 |
| 17000 Destruction Skin Lesion | Office | 20 | 19 | $25.45 | $509 |
By year: 2022 $67K for 1,157 services; 2023 $57K for 1,077 services; 2024 $66K for 965 services.
Medicare prescription drug claims, 2024
In 2024, the drug Steven W Queen prescribed most often to Medicare patients was Atorvastatin Calcium, with 409 prescriptions and refills. In total Steven W Queen wrote 13,660 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 409 | 1,087 | 104 | $3,860 |
| Montelukast Sodium Generic | 376 | 858 | 109 | $3,732 |
| Valsartan Generic | 360 | 946 | 92 | $8,225 |
| Levothyroxine Sodium Generic | 339 | 818 | 81 | $3,358 |
| Pantoprazole Sodium Generic | 324 | 755 | 93 | $3,210 |
| Amlodipine Besylate Generic | 276 | 644 | 66 | $1,157 |
| Metoprolol Succinate Generic | 261 | 633 | 64 | $3,973 |
| Famotidine Generic | 231 | 600 | 63 | $3,228 |
| Meloxicam Generic | 231 | 493 | 75 | $1,651 |
| Losartan Potassium Generic | 225 | 592 | 59 | $2,174 |
| Lorazepam Generic | 225 | 233 | 43 | $1,657 |
| Diclofenac Sodium Generic | 222 | 415 | 72 | $6,707 |
| Lisinopril Generic | 221 | 585 | 59 | $1,067 |
| Omeprazole Generic | 219 | 561 | 61 | $2,786 |
| Rosuvastatin Calcium Generic | 212 | 580 | 63 | $1,947 |
Brand drugs: 1,597 claims; generic drugs: 12,031 claims; opioid claims: 671.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Steven W Queen $1,160 ($1,160 in general payments such as food, travel and fees) from 12 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $288.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 6 | $288 |
| Novo Nordisk Inc NVO | 7 | $216 |
| Amgen Inc. AMGN | 6 | $101 |
| Pfizer Inc. PFE | 5 | $92.41 |
| GlaxoSmithKline, LLC. GSK | 4 | $87.71 |
| Viatris Specialty LLC | 4 | $86.24 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 3 | $72.17 |
| Lilly USA, LLC LLY | 3 | $60.89 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 3 | $56.76 |
| Abbvie Inc. ABBV | 2 | $44.36 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.